Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Contemporary drug therapies for multiple myeloma.
de la Puente P, Azab AK. de la Puente P, et al. Drugs Today (Barc). 2013 Sep;49(9):563-73. doi: 10.1358/dot.2013.49.9.2020941. Drugs Today (Barc). 2013. PMID: 24086952 Review.
Hypoxia promotes stem cell-like phenotype in multiple myeloma cells.
Muz B, de la Puente P, Azab F, Luderer M, Azab AK. Muz B, et al. Among authors: de la puente p. Blood Cancer J. 2014 Dec 5;4(12):e262. doi: 10.1038/bcj.2014.82. Blood Cancer J. 2014. PMID: 25479569 Free PMC article. No abstract available.
Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma.
de la Puente P, Quan N, Hoo RS, Muz B, Gilson RC, Luderer M, King J, Achilefu S, Salama NN, Vij R, Azab AK. de la Puente P, et al. Haematologica. 2016 Jul;101(7):e307-11. doi: 10.3324/haematol.2016.142190. Epub 2016 Apr 14. Haematologica. 2016. PMID: 27081175 Free PMC article. No abstract available.
PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.
Azab F, Vali S, Abraham J, Potter N, Muz B, de la Puente P, Fiala M, Paasch J, Sultana Z, Tyagi A, Abbasi T, Vij R, Azab AK. Azab F, et al. Among authors: de la puente p. Br J Haematol. 2014 Apr;165(1):89-101. doi: 10.1111/bjh.12734. Epub 2014 Jan 9. Br J Haematol. 2014. PMID: 24405121 Free article.
Molecularly targeted therapies in multiple myeloma.
de la Puente P, Muz B, Azab F, Luderer M, Azab AK. de la Puente P, et al. Leuk Res Treatment. 2014;2014:976567. doi: 10.1155/2014/976567. Epub 2014 Apr 16. Leuk Res Treatment. 2014. PMID: 24829804 Free PMC article. Review.
49 results